期刊文献+

丁胺卡那霉素和头孢曲松诱导细菌释放内毒素的实验研究 被引量:3

An empirical study on amikacin and ceftriaxone-induced release of endotoxin from bacterium
下载PDF
导出
摘要 目的探讨丁胺卡那霉素和头孢曲松在不同浓度和时间点诱导产ESBLs和非产ESBLs大肠埃希菌释放内毒素的量-效关系。方法常规方法分离、培养和鉴定产ESBLs和非产ESBLs大肠埃希菌;显色基质鲎试剂(微板法)分别测定0.1、0.5、1.0和10MIC的药物作用细菌2、4、8h后内毒素的释放量(查对内毒素标准曲线)以及细菌形态的变化。结果丁胺卡那霉素和头孢曲松诱导非产ESBLs大肠埃希菌以及丁胺卡那霉素在0.5MIC浓度范围内诱导产ESBLs大肠埃希菌释放的内毒素的量随着药物浓度和培养时间的增加而增加,而>0.5MIC浓度时释放的内毒素的量随药物浓度增加而显著减少。头孢曲松在10MIC范围内诱导产ESBLs大肠埃希菌释放的内毒素的量随药物浓度的增加而缓慢增加,在10MIC时释放量最大。不同作用时间内毒素释放量的顺序为8h>4h>2h。丁胺卡那霉素引起细菌从球杆状变为长杆状,而头孢曲松则引起细菌从杆状变为长链状或长丝状。结论头孢曲松诱导大肠埃希菌释放内毒素的能力显著强于丁胺卡那霉素,且引起细菌形态的变化更为显著。临床上在治疗感染性疾病时,应加大首次用药剂量,达到有效杀菌浓度而非抑菌浓度,以达到更好的临床治疗效果。 Objective To discuss amikacin and ceftriaxone-induced release of ESBLs and non-ESBLs from Escherichia coli and its relationship of endotoxic content-potency at different concentration and different time. Methods ESBLs and non-ESBLs-produced Escherichia coli were isolated, cultivated and identified by routine method. The releasing endotoxin contents at 0.1 MIC ( minimum inhibitory con- centrations), 0. 5 MIC, 1.0 MIC, 10 MIC after 2h, 4h, 8h of bacterium handling (find endotoxic standard curve) were measured respectively by colouration-basilaris-substantia tachypleus amebocyte lysate (mini-slab method) and the morphologic changes of bacteria were observed. Results The released endotoxic content of amikacinor ceftriaxone-induced non-ESBLs from Escherichia coli and amikacininduced ESBLs from Escherichia coli increased with antibiotic concentration and cultural time within the range of 0.5 MIC, but endotoxic content significantly diminished with increased antibiotic concentration when antibiotic concentration exceed 0.5 MIC. The released endotoxic content of ceftriaxone-induced ESBLs from Escherichia coli increased slowly with antibiotic concentration within the range of 10 MIC concentration. The released endotoxic content reached maximum at 10 MIC. The released endotoxic content at different bacterium concentrations was as the following oeder: 0.5 MIC 〉 1.0 MIC 〉 10 MIC. The released endotoxic content at different time was as the following order:8h 〉 4h 〉 2h. The shape of bacterium was changed by amikacin from sphero-rhabditiform to dolicho-rhabditiform, while by ceftriaxone changed from rhabditiform to long-chain-form or filament-form. Conclusion The capability of ceftriaxone-induced release of endotoxin from Escherichia coli is significantly stronger than that of amikacin, and the morphologic changes of bacteria caused by ceftriaxone were more significant. For Clinical treatmentg of infectious diseases the first dosage of medication should increase to reach the effective bactericidal concentration but not the bacteriostasis concentration in order to receive better therapeutic effects.
出处 《临床检验杂志》 CAS CSCD 北大核心 2007年第4期266-268,共3页 Chinese Journal of Clinical Laboratory Science
基金 重庆市卫生局课题(06-2-161)
关键词 大肠埃希茵 丁胺卡那霉素 头孢曲松 内毒素 释放实验 escherichia coli amikacin ceftriaxone endotoxin releasing experiment
  • 相关文献

参考文献3

二级参考文献8

共引文献60

同被引文献45

  • 1徐能武,袁建成,肖光夏,郑江,秦孝建.抗生素诱导革兰阴性杆菌释放内毒素的实验研究(一)[J].中华烧伤杂志,2001,17(2):11-15. 被引量:11
  • 2赵自刚,张静,牛春雨.多器官功能障碍综合征发病机制的某些研究进展[J].微循环学杂志,2004,14(3):80-83. 被引量:20
  • 3程碧军,李鹏,金升藻.黏附性菌毛K88的研究新进展[J].安徽农业科学,2007,35(2):446-447. 被引量:3
  • 4司文秀,杨继章,杨树民.抗菌药物诱导内毒素的产生及抗内毒素药物的研究进展[J].中国抗生素杂志,2007,32(8):454-458. 被引量:20
  • 5Dinarello C A. Proinflammatory and anti- inflammatory cytokines as mediators in the pathogenesis of septic shock [J]. Chest,1997,112(6):321S-329S.
  • 6ACCP/SCCM COnsensus Conference. Definitions of sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis [J]. Crit Care Med.1992,20 (6) :864-874.
  • 7Zhong W, Li Q, Zhang W, et al. Modulation of intestinal barrier and bacterial endotoxin production contributes to the beneficial effect of nicotinic acid on alcohol-induced endotoxemia and hepatic inflammation in rats. Biomolecules, 2015, 5:2643-58.
  • 8Tong SY, van Hal S J, Einsiedel L, et al. Impact of ethnicity and socio-economic status on Staphylococcus aureus bacteremia incidence and mortality: a heavy burden in Indigenous Australians. BMC Infect Dis, 2012, 12:249.
  • 9Joo SH. Lipid A as a drug target and therapeutic molecule. Biomol Ther, 2015, 23:510-6.
  • 10Bishop RE. Fundamentals of endotoxin structure and function. Contrib Microbiol, 2005, 12:1-27.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部